X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (5) 5
humans (5) 5
index medicus (5) 5
male (5) 5
middle aged (5) 5
aged (4) 4
chemotherapy (4) 4
abridged index medicus (3) 3
aged, 80 and over (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
carcinoma, non-small-cell lung - genetics (3) 3
carcinoma, non-small-cell lung - therapy (3) 3
france - epidemiology (3) 3
lung cancer (3) 3
lung neoplasms - genetics (3) 3
lung neoplasms - mortality (3) 3
lung neoplasms - pathology (3) 3
lung neoplasms - therapy (3) 3
mutation (3) 3
adult (2) 2
biomarkers (2) 2
carcinoma, non-small-cell lung - mortality (2) 2
care and treatment (2) 2
crizotinib (2) 2
internal medicine (2) 2
lung neoplasms - drug therapy (2) 2
medicine, general & internal (2) 2
neoplasm staging (2) 2
oncology (2) 2
prospective studies (2) 2
receptor, epidermal growth factor - genetics (2) 2
treatment outcome (2) 2
1st-line therapy (1) 1
adenocarcinoma - economics (1) 1
adenocarcinoma - epidemiology (1) 1
adenocarcinoma - secondary (1) 1
adenocarcinoma - therapy (1) 1
adolescent (1) 1
anesthesiology (1) 1
angiogenesis inhibitors (1) 1
antibodies, monoclonal - administration & dosage (1) 1
antibodies, monoclonal - adverse effects (1) 1
antineoplastic agents, immunological - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
apoptosis (1) 1
b7-h1 antigen - genetics (1) 1
b7-h1 antigen - metabolism (1) 1
bevacizumab - administration & dosage (1) 1
bevacizumab - adverse effects (1) 1
biomarkers, tumor (1) 1
biomarkers, tumor - genetics (1) 1
biphosphonates (1) 1
bone metastases (1) 1
bone neoplasms - economics (1) 1
bone neoplasms - epidemiology (1) 1
bone neoplasms - secondary (1) 1
bone neoplasms - therapy (1) 1
breast-cancer (1) 1
cancer (1) 1
cancer therapies (1) 1
carboplatin (1) 1
carcinoma, large cell - economics (1) 1
carcinoma, large cell - epidemiology (1) 1
carcinoma, large cell - secondary (1) 1
carcinoma, large cell - therapy (1) 1
carcinoma, non-small-cell lung - drug therapy (1) 1
carcinoma, non-small-cell lung - economics (1) 1
carcinoma, non-small-cell lung - epidemiology (1) 1
carcinoma, non-small-cell lung - pathology (1) 1
carcinoma, non-small-cell lung - secondary (1) 1
carcinoma, squamous cell - economics (1) 1
carcinoma, squamous cell - epidemiology (1) 1
carcinoma, squamous cell - secondary (1) 1
carcinoma, squamous cell - therapy (1) 1
cisplatin (1) 1
cisplatin - administration & dosage (1) 1
cisplatin - adverse effects (1) 1
class i phosphatidylinositol 3-kinases (1) 1
classification (1) 1
clinical outcomes (1) 1
clinical trials (1) 1
clinical-practice (1) 1
combination (1) 1
combined modality therapy (1) 1
complications (1) 1
cost-benefit analysis (1) 1
costs (1) 1
creatinine - blood (1) 1
critical care medicine (1) 1
diphosphonates - therapeutic use (1) 1
disease (1) 1
disease-free survival (1) 1
dosage and administration (1) 1
double-blind (1) 1
drug therapy (1) 1
emergency medicine (1) 1
endothelial growth factors (1) 1
endothelial growth-factor (1) 1
endothelium (1) 1
epidermal growth factor (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2015, Volume 387, Issue 10026, pp. 1405 - 1414
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10026, pp. 1415 - 1426
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2018, Volume 378, Issue 22, pp. 2093 - 2104
Journal Article
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 03/2011, Volume 6, Issue 3, pp. 576 - 582
The aim of this prospective, observational, multicenter study was to examine the epidemiology and management costs of bone metastatic disease (BMD) in patients... 
Zoledronic acid | Costs | Bone metastases | Non-small cell lung cancer | Biphosphonates | SURVIVAL | SOLID TUMORS | PHASE-III | BREAST-CANCER | ONCOLOGY | RESPIRATORY SYSTEM | PROSTATE-CANCER | DISEASE | SKELETAL-RELATED EVENTS | DOUBLE-BLIND | COMPLICATIONS | Markov Chains | Prospective Studies | Bone Neoplasms - therapy | Follow-Up Studies | Humans | Middle Aged | Bone Neoplasms - secondary | Bone Neoplasms - epidemiology | Lung Neoplasms - pathology | Male | Small Cell Lung Carcinoma - secondary | Carcinoma, Large Cell - secondary | Carcinoma, Large Cell - epidemiology | Carcinoma, Non-Small-Cell Lung - secondary | Carcinoma, Squamous Cell - economics | Aged, 80 and over | Diphosphonates - therapeutic use | Female | Retrospective Studies | Radiotherapy Dosage | France - epidemiology | Carcinoma, Squamous Cell - epidemiology | Carcinoma, Non-Small-Cell Lung - epidemiology | Carcinoma, Squamous Cell - therapy | Survival Rate | Treatment Outcome | Combined Modality Therapy | Lung Neoplasms - therapy | Adenocarcinoma - secondary | Carcinoma, Non-Small-Cell Lung - economics | Carcinoma, Non-Small-Cell Lung - therapy | Lung Neoplasms - epidemiology | Adenocarcinoma - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Carcinoma, Large Cell - economics | Cost-Benefit Analysis | Health Care Costs - statistics & numerical data | Carcinoma, Squamous Cell - secondary | Aged | Bone Neoplasms - economics | Lung Neoplasms - economics | Small Cell Lung Carcinoma - therapy | Adenocarcinoma - economics | Adenocarcinoma - epidemiology | Neoplasm Staging | Small Cell Lung Carcinoma - epidemiology | Carcinoma, Large Cell - therapy | Small Cell Lung Carcinoma - economics | Index Medicus | Life Sciences | Santé publique et épidémiologie
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.